tradingkey.logo
tradingkey.logo
Search

First Tracks Biotherapeutics Ord Shs

TRAX
Add to Watchlist
44.040USD
-3.740-7.83%
Close 07-31 16:00ETQuotes delayed by 15 min
1.54BMarket Cap
--P/E TTM

First Tracks Biotherapeutics Ord Shs

44.040
-3.740-7.83%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-7.83%

5 Days

+23.99%

1 Month

+128.19%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

Key Figures
47.700Open
47.700High
869.70KVolume
--P/E TTM
LossP/E Dynamic
--Dividend TTM
2.50%Turnover Ratio
47.780Prev. Close
43.530Low
30.86MTurnover
--P/E Static
5.94P/B
0.00%Div Yield TTM
--ROA
26.80052wk High
0.75Volume Ratio
--Net Profit
34.75MShares
--EPS TTM
--Beta
--ROE
14.79052wk Low
8.73%Amplitude
--Gross Margin
1.54BMarket Cap
14.88Reward/Risk
9.30%Risk Rate

First Tracks Biotherapeutics Ord Shs News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 8 analysts
Buy
Current Rating
53.714
Target Price
+21.97%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
First Tracks Biotherapeutics Ord Shs
TRAX
8
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(2)
Neutral(1)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
1.140
Buy
RSI(14)
71.120
Buy
STOCH(KDJ)(9,3,3)
74.533
Neutral
ATR(14)
4.367
High Vlolatility
CCI(14)
127.751
Buy
Williams %R
26.832
Buy
TRIX(12,20)
3.289
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
43.514
Buy
MA10
40.314
Buy
MA20
35.530
Buy
MA50
24.473
Buy
MA100
--
--
MA200
22.930
Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

First Tracks Biotherapeutics Ord Shs Info

Ticker Symbol
Company
CEO
Website

Shareholders

Shareholders
Shareholders
Proportion
EcoR1 Capital, LLC
27.08%
TCG Crossover Management, LLC
9.95%
BlackRock Institutional Trust Company, N.A.
6.53%
Faga (Daniel R)
3.52%
Lizzul (Paul F.)
1.47%
Other
51.45%

FAQs

What is the current price of First Tracks Biotherapeutics Ord Shs (TRAX)?

The current price of First Tracks Biotherapeutics Ord Shs (TRAX) is 44.04.

What is the symbol of First Tracks Biotherapeutics Ord Shs?

The ticker symbol of First Tracks Biotherapeutics Ord Shs is TRAX.

What is the 52-week high of First Tracks Biotherapeutics Ord Shs?

The 52-week high of First Tracks Biotherapeutics Ord Shs is 26.80.

What is the 52-week low of First Tracks Biotherapeutics Ord Shs?

The 52-week low of First Tracks Biotherapeutics Ord Shs is 14.79.

What is the market capitalization of First Tracks Biotherapeutics Ord Shs?

The market capitalization of First Tracks Biotherapeutics Ord Shs is 1.54B.

Is First Tracks Biotherapeutics Ord Shs (TRAX) currently rated as Buy, Hold, or Sell?

According to analysts, First Tracks Biotherapeutics Ord Shs (TRAX) has an overall rating of Buy, with a price target of 53.71.

What is the Earnings Per Share (EPS TTM) of First Tracks Biotherapeutics Ord Shs (TRAX)?

The Earnings Per Share (EPS TTM) of First Tracks Biotherapeutics Ord Shs (TRAX) is -4.78.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.